Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

High quality variant calls from multiple dog genome project - Run2

ABSTRACT: Dog Biomedical Variant Database Consortium (DBVDC) was established to aggregate whole genome sequencing data from a variety of projects examining dog biomedical and morphological phenotypes.The VCF was produced using the BWA-GATK best practices pipeline.

INSTRUMENT(S): Illumina NovaSeq 6000, Illumina HiSeq 2500

ORGANISM(S): Canis Lupus Familiaris

SUBMITTER: Unibe

PROVIDER: PRJEB32865 | EVA | 2019-06-11

REPOSITORIES: EVA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	dogs.590publicSamples.accessioned.vcf.gz	Vcf
	dogs.590publicSamples.accessioned.vcf.gz.csi	Vcf
	dogs.590publicSamples.accessioned.vcf.gz.tbi	Vcf
	dogs.590publicSamples.vcf.gz	Vcf
	dogs.590publicSamples.vcf.gz.tbi	Vcf

Items per page:

1 - 5 of 5

Similar Datasets

Best practices for eCLIP experiments and analysis [poor quality]

Project description:Best practices for eCLIP experiments and analysis [poor quality]

| PRJNA421344 | ENA

Best practices for eCLIP experiments and analysis [uncertain quality]

Project description:Best practices for eCLIP experiments and analysis [uncertain quality]

| PRJNA421346 | ENA

Phase One Resequencing for 10,000 Dog Genome Consortium

Project description:The international Dog10K consortium (Dog10K) was established to capture the genetic diversity that underlies the phenotypic and geographical variability of modern canids worldwide. The VCF was produced using a BWA-GATK best practices pipeline and input sequences of greater than 10x coverage.

2023-05-21 | PRJEB62420 | EVA

The SEQC2 epigenomics quality control (EpiQC) study

Project description:We present a multi-platform assessment and a global resource for epigenetics research from the FDA's Epigenomics Quality Control (EpiQC) Group. The study design leverages seven human cell lines that are designated as reference materials and publicly available from the National Institute of Standards and Technology (NIST) and Genome in a Bottle (GIAB) consortium. These samples were subject to a variety of genome-wide methylation interrogation approaches across six independent laboratories, with a primary focus on 5-methylcytosine modifications.

2021-10-26 | GSE186383 | GEO

The SEQC2 epigenomics quality control (EpiQC) study [methylation array]

2023-04-21 | GSE230132 | GEO

Project description:Koala Genome Consortium Projects

| PRJEB19389 | ENA

Best practices for eCLIP experiments and analysis

Project description:Best practices for eCLIP experiments and analysis

| PRJNA421341 | ENA

The NIHR BioResource Rare Diseases BRIDGE consortium sequencing projects

Project description:The NIHR BioResource Rare Diseases BRIDGE consortium is a collaboration between 13 Rare Disease projects that aim to discover the genetic sequence variants underlying unresolved inherited disorders and to improve identification of already identified high penetrance variants. BRIDGE projects cover a variety of rare disease research areas including Cardiovascular, Infection and Immunity and Neuroscience. The consortium aims to sequence 8,000 samples across the different projects by 2017.

| EGAS00001001012 | EGA

The Exome Aggregation Consortium (ExAC) v0.3

Project description:The Exome Aggregation Consortium (ExAC) is a coalition of investigators seeking to aggregate and harmonize exome sequencing data from a variety of large-scale sequencing projects, and to make summary data available for the wider scientific community.

2015-02-26 | PRJEB8661 | EVA

ena-DATASET-GoT2D/T2D-GENES-08-07-2016-21:22:44:693-1130 - samples

Project description:The T2D-GENES/GoT2D 13K exome sequencing study includes ~13,000 samples, half T2D cases and half T2D controls, from five ancestries (~5K Europeans, ~2K each of African-American, East-Asian, South-Asian, and Hispanic). Samples underwent deep exome sequencing, with SNVs and INDEls called according to GATK best practices; variant sites were then filtered according to the GATK best practices, and then samples and variants underwent further filtering based on aggregate genotype quality as described in Fuchsberger et al. (e.g. low call rate, excess heterozygosity for samples, low call rate or coverage for variants). Please note that one of the samples in the T2D-GENES vcf does not have phenotype data.

| EGAD00001002246 | EGA

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data